EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS139-35466 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr22:36850410-36852260 
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF5MA0599.1chr22:36851322-36851332GGGGCGGGGC-6.02
NRF1MA0506.1chr22:36851043-36851054GCGCCTGCGCA+6.62
Nr2f6(var.2)MA0728.1chr22:36850465-36850480GAGGTCAGGAGTTCA+6.22
SP1MA0079.4chr22:36851178-36851193GAGGGGCGTGGCTTT-6.58
SP4MA0685.1chr22:36851176-36851193CGGAGGGGCGTGGCTTT-6.25
SRFMA0083.3chr22:36851292-36851308TCGCCTTATATGGGCA+6.1
SRFMA0083.3chr22:36851292-36851308TCGCCTTATATGGGCA-6.71
Number of super-enhancer constituents: 27             
IDCoordinateTissue/cell
SE_01080chr22:36850726-36852262Adrenal_Gland
SE_01722chr22:36850607-36852913Aorta
SE_23071chr22:36850671-36852560Colon_Crypt_1
SE_23740chr22:36850718-36852282Colon_Crypt_2
SE_24731chr22:36850718-36852420Colon_Crypt_3
SE_26443chr22:36850607-36852611Duodenum_Smooth_Muscle
SE_27096chr22:36850705-36852669Esophagus
SE_27650chr22:36850647-36852400Fetal_Intestine
SE_31378chr22:36850633-36852734Gastric
SE_38695chr22:36850357-36852234HUVEC
SE_40577chr22:36850636-36852007K562
SE_41064chr22:36850677-36852892Left_Ventricle
SE_42094chr22:36850596-36852908Lung
SE_47671chr22:36850712-36852254Pancreas
SE_49127chr22:36850680-36852736Right_Atrium
SE_49784chr22:36850757-36851955Right_Ventricle
SE_50050chr22:36850646-36852826Sigmoid_Colon
SE_51467chr22:36849566-36852911Skeletal_Muscle
SE_52340chr22:36850703-36852749Small_Intestine
SE_53283chr22:36850603-36852908Spleen
SE_54687chr22:36849576-36855238Stomach_Smooth_Muscle
SE_55607chr22:36850710-36852282Thymus
SE_57815chr22:36850729-36851204VACO_503
SE_57815chr22:36851243-36851946VACO_503
SE_62151chr22:36773097-36852649Toledo
SE_63127chr22:36801020-36866853Tonsil
SE_65459chr22:36849505-36852516Pancreatic_islets
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr223685160036852198
Enhancer Sequence
CAGTGGCTCA CGCCTGTAAT CCCAGCACTT TGGGAGGCCG AGGAGGGTGG ATCACGAGGT 60
CAGGAGTTCA AGACCAGCCT GGCCAATATG GCGAAACCCC GTCTCTACTA AAAATACAAA 120
AATTAGCCAG GCGTGGTGGT GTGCGCCTGT AGTTTCAGCT ACTTGGGAGG CTGAGGCAGG 180
AGAATAGCTT GAACCCGGGA GGCGGAGGTT GCAGTGAGCC GAGATCACGC CACTGCACTC 240
CAGCCTGGCA ACAGAGCGAG ACTCTGTCTC AAAAAAAAAA AAAAAAAAAA AAAAAAAAGA 300
AAAAGAAGAA AAAGAAAAAA GAGAAAGAAG GAAAGAATTA CATAACAGTA AGCAACCTAG 360
CTAGATTTGA ACCAGGCCCT GCAGTTCTAA AGCACTGGCT TTTGCGGAGC GGCACTCACT 420
CCGCATCGTG GCATAGGTAG ATTTCTTTTC TAAAGGTGAG GTCAGTGCTG GGCACTTAGC 480
AGGCGCCCGG TGGGCTGCGC CGTCCTGGAG GAAGGCTGAT TCCTCCCACC CCGACTCCTG 540
GCTCGTGGGT GGGTAATCCA GCACATTCTC CCCACCCCGG CAACCAACTT TGTGGCCGAA 600
CAAGCCCTCC CCGGCTTGTT CCGCTGGTCC CAGGCGCCTG CGCATCCGGA CACGATGAGG 660
AGCAGGTGCG CGGGGCCGGG GTGTGTTCGA GGGGGTCGTG CGCGCCTGGG CTGCCTCCCC 720
GCGGACGGCG GACTGGGCCG GGGCGGCGCT TCCTGGCAGA GAGGCGCGGA GGGGCGTGGC 780
TTTGGAGAGG TGCCCCCGGC GGGCTGGCGG CCTGGCTGCG GTGAAAGGCG GGCGGACGCA 840
GGTGACGACA ACCGCTCCAT AAAGGGCGCC GCGGCGCGAC GCTCGCCTTA TATGGGCAGG 900
CTCGGCGCGG GAGGGGCGGG GCGTTCCACC CAGCTGGCTC CGCACCGAGG CCCGGCCGAA 960
CCCCCGAGGG GGGAAACTTC TCTGCGAGGG TGGAGCCTCC TCAGCGGCGT CCCCAGGTCC 1020
CGAGAGGGGT CCCTACCCAG GCTAAGACTC ACGACGGGCT CCACCCTGCA GGGGCTCAAC 1080
TTGCAGAAAC CCTGGGGCCT GCCTTCCCCA GGGGTCTGCC CTCCTCAGGC CCTGCTAGGG 1140
CACTGACTCG GTTTGTGCTG TGTGGCGTTT TTTCCTTCAC CCCACCTGGG CCGCAGGTCC 1200
TCGCTAGATA GCCGAGGGAG GGTCCTTTAA GTGAGCTCAC CTCGGAGCCC CCAGATAACC 1260
AAGCCTGAGC CTCCCGGCTA CATGGCGAGG CTTCCCCAAT CCGGTCAGCC CCAAGCAGGT 1320
GCCTTTCTCT AACTGGCACA AAGGAAGTCT CCTAGCCAGG CTGAGCCCAA GCCTCGGTAA 1380
ACATGAGCCT TGGATCCACT GGAAGTGTTT GGCTAACTGG GCCCTTCTTG GCCAGACAAG 1440
ACTTTAACCC TAAGAGGAAG CTGCCAGCAT GACGCAGCCC ACCATATTCT CCCTCCAAGC 1500
TCTCTTCATA GCCCGGGTCC TTAAAAACCC AAATCTGTCC AATTGCTACT TGCCGTCCAC 1560
TCGTTGACAG TTACTCCGCT TCACAGCCTC CCGATCACCT GAGTGTCCTC CCTCGGCTCA 1620
GTGCACAGGG CTCTGTGAGC TTACAGTTCC CTGGTTGCCG TTCCGTGCCT CCCAGCCCTG 1680
CACCTGCTGC TCCTTTCTGG AAAGCCCTTT CCTTGCACAC TCCCAGACAC GTGCTCACCC 1740
TTCAGAGAGA TACTTCTTAG CGTCTTCTTC CTGACATTTG TAGTGATTAC TTAACCTTTC 1800
TGAGCATCAA TTTCTTCATC TGCAAGATGG GGGTAAAATA ATCCCCACCT 1850